Free clinic treats the uninsured
FernCare to open to patients Aug. 7.
Read more on Royal Oak Daily Tribune
Vivus Plunges Most Ever After U.S. Review of Qnexa
Vivus Inc. shares plunged the most ever in New York trading the day after U.S. reviewers recommended against approval of its Qnexa diet pill, a decision that analysts say may threaten makers of competing drugs.
Read more on BusinessWeek
Related posts:
- FDA panel turns down Vivus’ diet drug
- Vivus’s Qnexa Will Become Decision Resources’ Clinical Gold Standard In 2013 For The Treatment Of Obesity
- Latest Xenical News
- Vivus Fails to Win FDA Panel’s Recommendation for Weight-Loss Pill Qnexa
- FDA Rejects S.Bay Drugmaker’s New Weight Loss Pill
Tags: clinic, Free, Treats, uninsured